ZYNERBA PHARMACEUTICALS, INC. Net Cash Provided by (Used in) Continuing Operations
ZYNERBA PHARMACEUTICALS, INC. reported Net Cash Provided by (Used in) Continuing Operations of $46.53 million for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-09.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:NetCashProvidedByUsedInContinuingOperations · last filed 2017-05-09
- ZYNERBA PHARMACEUTICALS, INC. net cash provided by (used in) continuing operations for the quarter ending 2017-03-31 was $46.53M.
- ZYNERBA PHARMACEUTICALS, INC. net cash provided by (used in) continuing operations for the quarter ending 2016-03-31 was -$4.70M.
- ZYNERBA PHARMACEUTICALS, INC. net cash provided by (used in) continuing operations for fiscal 2016 was -$10.55M, a 132.77% decline from fiscal 2015.
- ZYNERBA PHARMACEUTICALS, INC. net cash provided by (used in) continuing operations for fiscal 2015 was $32.18M, a 250.72% increase from fiscal 2014.
- ZYNERBA PHARMACEUTICALS, INC. net cash provided by (used in) continuing operations for fiscal 2014 was $9.18M.
| Period end | Net Cash Provided by (Used in) Continuing Operations 3 month | Net Cash Provided by (Used in) Continuing Operations 12 month |
|---|---|---|
| 2017-03-31 | $46.53M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | -$10.55M 10-K · filed 2017-03-27 | |
| 2016-03-31 | -$4.70M 10-Q · filed 2017-05-09 | |
| 2015-12-31 | $32.18M 10-K · filed 2017-03-27 | |
| 2014-12-31 | $9.18M 10-K · filed 2017-03-27 |